Skip to content

Clinical trials

Completed Phase 1/2 Central Nervous System Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 1/2 Status: Completed Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20013
20024
20032
20044
20053
20062
20072
20093
20103
20111
20131
20143
20172
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
New Approaches to Brain Tumor Therapy Consortium7
Duke University4
Radiation Therapy Oncology Group4
Alliance for Clinical Trials in Oncology3
Memorial Sloan Kettering Cancer Center3
National Cancer Institute (NCI)3
Jonsson Comprehensive Cancer Center2
Asan Medical Center1
BBB-Therapeutics B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms51
Glioblastoma37
Gliosarcoma34
Brain Neoplasms30
Astrocytoma23
Oligodendroglioma18
Glioma15
Medulloblastoma5
Neoplasm Metastasis4
Ependymoma3

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.